TECHDOW PHARMA ENGLAND LIMITEDActive
Key figures
Ratios
2025Balance sheet structure
Filed accounts2019–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Turnover | 31,674,721 | 42,844,591 | 49,912,155 | 39,675,728 | 48,765,902 |
| Profit for the year | -6,626,980 | 5,439,048 | 5,605,796 | 730,293 | 870,504 |
| Cash at bank and in hand | 9,230,843 | 10,272,487 | 13,885,969 | 9,478,356 | 6,764,715 |
| Total assets | 31,179,597 | 37,399,618 | 35,320,005 | 43,088,440 | 47,271,798 |
| Total liabilities | 44,915,293 | 45,696,266 | 38,010,857 | 45,048,999 | 48,361,853 |
| Net assets / total equity | -13,735,696 | -8,296,648 | -2,690,852 | -1,960,559 | -1,090,055 |
| Average number of employees | 8 | 8 | 8 | 11 | 12 |
| Average pay (per year) | 86,364 | 136,507 | 135,973 | 141,538 | 131,732 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: TECHDOW PHARMA ENGLAND LIMITED
Company
TECHDOW PHARMA ENGLAND LIMITED is a private limited company registered with Companies House under company number 10513412. It was incorporated on 6 Dec 2016. Its status is active. The registered office is in Guildford (GU2). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).
Accounts
The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files full accounts. Turnover was £48,765,902. Profit for the year was £870,504. Net assets were −£1,090,055, up 44.4% on the previous year. Cash at bank and in hand was £6,764,715. Total assets were £47,271,798 and total liabilities £48,361,853. The company had an average of 12 employees. Figures are available for 7 financial years (2019–2025).
Control and charges
The company has 2 current directors. One person with significant control is registered.
Filing deadlines
The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 19 Dec 2026.